Advancing Beauty Through Science
To become a globally trusted biotechnology company that transforms aesthetic medicine through innovation, quality, and scientific excellence.
Advancing the future of aesthetic medicine through innovative biotechnology, world-class manufacturing, and global partnerships.
A Foundation of Absolute Precision
We believe true aesthetic innovation begins with uncompromising quality. By combining state-of-the-art research with rigorous global standards, Selatox is creating a safer, more precise foundation for modern beauty and wellness. As Indonesia’s first specialized biopharmaceutical center, we are redefining what is possible in aesthetic medicine.

To become a globally trusted biotechnology company that transforms aesthetic medicine through innovation, quality, and scientific excellence.
We develop and manufacture high-quality aesthetic therapies through advanced biotechnology and pharmaceutical-grade manufacturing, creating lasting value for patients, healthcare professionals, and partners worldwide.
True innovation requires honesty—complete transparency, strict clinical safety, and absolute trust in every vial we produce.

Precision · Purity · Confidence
Botulinum Toxin Type A
A high-purity formulation engineered through advanced biotechnology.
Our Business
We develop precision toxin formulations and partner with leading clinics worldwide to bring trusted, scalable aesthetic solutions to every market we serve.
Engineered for precision and consistency, our facility integrates GMP-aligned workflows, sterile production capabilities, and a modular design that scales with global demand.
A dedicated manufacturing building designed with clean zoning, controlled circulation, and GMP-ready operational flow.
Equipped for sterile production, precision fill-finish, environmental monitoring, and validated quality control operations.
Modular capacity planning and integrated utility systems support long-term expansion while maintaining consistent product quality.
Core research programs across formulation, process development, and clinical readiness.
SELATOXIN (Botulinum Toxin Type A)
Global Phase III Clinical Trial (Glabellar Lines)
Phase III
2028
SELATOXIN Halal Version
Drug Substance Development
Development
2030
We're assembling a team of scientists, strategists, and operators who believe the next era of bio-aesthetics will be engineered in Indonesia — and shared with the world.
Cikarang, West Java
Cikarang, West Java
Depok, West Java